After getting denied membership to the Mag 7 club, Netflix stock gets revenge on Nvidia, Apple with big demand from the best mutual funds.
U.S. drugmaker Eli Lilly on Monday said it has appointed insider Lucas Montarce as its new chief financial officer, effective immediately, months after former CFO Anat Ashkenazi stepped down to join Google parent Alphabet. This executive change arrives at a critical juncture for Eli Lilly, as the company invests billions to expand manufacturing capacity and meet soaring demand for its diabetes and weight loss drugs, Mounjaro and Zepbound. Lilly and Danish rival Novo Nordisk are leaders in the burgeoning market for new weight loss drugs, which some analysts project could exceed $150 billion by the early 2030s.
We recently compiled a list of the 7 Best Big Company Stocks to Buy Now. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other big company stocks. Mega-cap stocks—major technology companies to be precise—continued to drive a disproportionate share of the total US stock […]